Pramiconazole
Appearance
This article needs additional citations for verification. (January 2021) |
Clinical data | |
---|---|
Routes of administration | By mouth |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C35H39F2N7O4 |
Molar mass | 659.739 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Pramiconazole is a triazole antifungal which was under development by Barrier Therapeutics for the treatment of acute skin and mucosal fungal infections but was never marketed.[1][2]
References
[edit]- ^ "Pramiconazole - AdisInsight".
- ^ Geria AN, Scheinfeld NS (September 2008). "Pramiconazole, a triazole compound for the treatment of fungal infections". IDrugs: The Investigational Drugs Journal. 11 (9): 661–70. PMID 18763217.